Mark Dean-Netscher joins Penn Pharma

pharmafile | May 18, 2011 | Appointment | Manufacturing and Production, Research and Development |  appointment, manufacturing and production, research and development 

Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer.

He has more than 20 years experience in the pharmaceutical manufacturing industry and in his new role will manage the operational arm of the South Wales headquartered company.

Mark has held a number of senior industry positions, including heading up Reckitt Benckiser’s global healthcare operation and, most recently, overseeing a significant portion of Catalent’s global production facilities as operations VP, international and Europe.

He said: “I am looking forward to joining this dynamic company where I can employ my extensive experience in leading operations across Europe and the USA, and technical expertise in dosage forms, API manufacture and clinical trials to further grow the business in what will be my first post in Wales.”